A61K 31/202
Having three or more double bonds
Official title: having three or more double bonds, e.g. linolenic (eicosanoids, e.g. leukotrienes A61K31/557)
A61K31/202 (Having three or more double bonds) appears on 1,861 US grants and 3,447 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,861
- Published applications
- 3,447
- Assignees
- 1,076
- Inventors
- 3,947
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 0 | 0 |
| 1994 | 4 | 0 |
| 1995 | 6 | 0 |
| 1996 | 28 | 0 |
| 1997 | 47 | 0 |
| 1998 | 13 | 0 |
| 1999 | 19 | 0 |
| 2000 | 16 | 0 |
| 2001 | 19 | 6 |
| 2002 | 24 | 48 |
| 2003 | 31 | 57 |
| 2004 | 11 | 65 |
| 2005 | 13 | 63 |
| 2006 | 17 | 108 |
| 2007 | 14 | 96 |
| 2008 | 13 | 80 |
| 2009 | 16 | 100 |
| 2010 | 29 | 126 |
| 2011 | 64 | 121 |
| 2012 | 56 | 122 |
| 2013 | 84 | 178 |
| 2014 | 91 | 241 |
| 2015 | 114 | 204 |
| 2016 | 118 | 232 |
| 2017 | 149 | 195 |
| 2018 | 134 | 203 |
| 2019 | 101 | 184 |
| 2020 | 113 | 167 |
| 2021 | 130 | 194 |
| 2022 | 95 | 172 |
| 2023 | 69 | 139 |
| 2024 | 81 | 136 |
| 2025 | 77 | 114 |
| 2026 | 61 | 96 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for identifying pre-disposition to cognitive decline and agents for reducing or preventing cognitive decline, or improving cognitive ability29 Sep 2026US 12,746,255 B2Societe des Produits Nestle S. A.
- Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto15 Sep 2026US 12,734,145 B2Children's Healthcare of Atlanta, Inc.
- Piperidine urea derivatives for cancer therapy15 Sep 2026US 12,734,164 B2NeuroPn Therapeutics, Inc.
- Core four dietary supplement system15 Sep 2026US 12,734,221 B2
- Method of increasing the population of Dialister spp. in the gut microbiome8 Sep 2026US 12,728,109 B2Dsm IP Assets B.V.
- Very long chain fatty acids for use in mineralization8 Oct 2026US 2026/0306434 A1Epax Norway AS
- Methods for Inhibiting the Progression of Neurogenerative Diseases8 Oct 2026US 2026/0306435 A1BioJiva LLC
- Composition, methods and uses8 Oct 2026US 2026/0306509 A14E Therapeutics, Inc.
- Compositions and compounds including lithium orotate1 Oct 2026US 2026/0294962 A1Atlantis Software Company
- Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids24 Sep 2026US 2026/0283951 A1Children's Medical Center Corporation
Most cited
By later US patents
- Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use354US 5,091,171 A1992
- Process for the heterotrophic production of microbial products with high concentrations of omega-3 highly unsaturated fatty acids354US 5,130,242 APhycotech, Inc. · 1992
- Fatty acid composition290US 5,502,077 ANorsk Hydro A/S · 1996
- Fatty acid composition226US 5,656,667 ANorsk Hydro A/S · 1997
- Methods and compositions for improving digestion and absorption in the small intestine216US 5,977,175 ACedars-Sinai Medical Center · 1999